Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7642817 | 0.84 | TSHR (0.45) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL23250879 | 0.83 | NAAA (0.46) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL17765046 | 0.83 | NAAA (0.46) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL6102145 | 0.81 | IDO1 (0.50) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL29694804 | 0.81 | SLC6A4 (0.40) | IDO1KMT2ASLC6A2SLC6A3RAB9A | |
| SCHEMBL22732123 | 0.81 | IDO1 (0.44) | ALDH1A1IDO1L3MBTL1KMT2ARAB9A | |
| SCHEMBL22732283 | 0.81 | MEN1 (0.44) | ALDH1A1IDO1L3MBTL1KMT2AMAPK1 | |
| SCHEMBL816466 | 0.80 | L3MBTL1 (0.48) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL12392478 | 0.80 | L3MBTL1 (0.48) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL865387 | 0.78 | CA12 (0.53) | CA12CA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4263672-B1 | SELF-BLOWING ISOCYANATE-FREE POLYURETHANE FOAMS | UNIV LIEGE (BE) | 2024-10-09 | — | — | EP | disclosed |
| US-20230416487-A1 | SELF-BLOWING ISOCYANATE-FREE POLYURETHANE FOAMS | Université de Liège (BE) | 2023-12-28 | — | — | US | disclosed |
| EP-4263672-A1 | SELF-BLOWING ISOCYANATE-FREE POLYURETHANE FOAMS | Université de Liège (BE) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022128822-A1 | SELF-BLOWING ISOCYANATE-FREE POLYURETHANE FOAMS | Université de Liège (BE) | 2022-06-23 | — | — | WO | disclosed |
| EP-4015563-A1 | SELF-BLOWING ISOCYANATE-FREE POLYURETHANE FOAMS | Université de Liège (BE) | 2022-06-22 | — | — | EP | disclosed |
| US-8324176-B2 | Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2012-12-04 | — | — | US | disclosed |
| US-8324176-B2 | Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2012-12-04 | — | — | US | disclosed |
| US-7888487-B2 | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2011-02-15 | — | — | US | disclosed |
| EP-1364958-B1 | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF | KISSEI PHARMACEUTICAL (JP) | 2010-09-08 | — | — | EP | disclosed |
| EP-1364958-B1 | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF | KISSEI PHARMACEUTICAL (JP) | 2010-09-08 | — | — | EP | disclosed |
| US-7375087-B2 | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2008-05-20 | — | — | US | disclosed |
| US-7294618-B2 | Glucopyranosyloxypyrazole derivatives and medicinal use thereof | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2007-11-13 | — | — | US | disclosed |
| US-7294618-B2 | Glucopyranosyloxypyrazole derivatives and medicinal use thereof | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2007-11-13 | — | — | US | disclosed |
| US-7294618-B2 | Glucopyranosyloxypyrazole derivatives and medicinal use thereof | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2007-11-13 | — | — | US | disclosed |
| US-7217697-B2 | Glucopyranosyloxypyrazole derivative medicinal composition containing the same medicinal use thereof and intermediate therefor | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2007-05-15 | — | — | US | disclosed |
| US-20060128635-A1 | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2006-06-15 | — | — | US | disclosed |
| EP-1550668-A1 | PYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, MEDICINAL USE THEREOF AND INTERMEDIATE IN PRODUCING THE SAME | Kissei Pharmaceutical Co., Ltd. (JP) | 2005-07-06 | — | — | EP | disclosed |
| US-20040116357-A1 | For prophylaxis and therapy of hyperglycemia such as diabetes, diabetic complications or obesity | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1364958-A1 | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF | Kissei Pharmaceutical Co., Ltd. (JP) | 2003-11-26 | — | — | EP | disclosed |
| US-4569797-A | REACTING CARBONYL SULFIDE WITH METAL MERCAPTIDE IN APROTIC SOLVENT | VIRGINIA CHEMICALS INC. (US) | 1986-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128635-A1 | Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same | SLC2A3, SLC2A1, SLC5A1 | CA12 3140/4885CA1 3104/4885CA2 1991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.